Intestinal uptake of nateglinide by an intestinal fluorescein transporter

Biochimica et Biophysica Acta - Biomembranes

Volumn 1668, Issue 2, 2005, Pages 190-194

  Itagaki, Shirou ^a   Otsuka, Yukio ^a   Kubo, Sayaka ^a   Okumura, Hideo ^a   Saito, Yoshitaka ^a   Kobayashi, Masaki ^a   Hirano, Takeshi ^a   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Absorption; Caco 2; Fluorescein; Intestine; Monocarboxylate transporter; Nateglinide

Indexed keywords

BENZOIC ACID; CARRIER PROTEIN; FLUORESCEIN; HYDROGEN; NATEGLINIDE; PRAVASTATIN; PROTEIN INHIBITOR; SALICYLIC ACID;

ARTICLE; CARCINOMA CELL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG UPTAKE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMALL INTESTINE ABSORPTION;

EID: 14544304534     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2004.12.005     Document Type: Article

References (25)

1. H. Shinkai, K. Toi, I. Kumashiro, Y. Seto, M. Fukuma, K. Dan, and S. Toyoshima N-acylphenylalanines and related compounds. A new class of oral hypoglycemic agents J. Med. Chem. 31 1988 2092 2097
2. S. Fujitani, and T. Yada A novel d-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx Endocrinology 134 1994 1395 1400
3. M. Akiyoshi, M. Kakei, M. Nakazaki, and H. Tanaka A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells Am. J. Physiol. 268 1995 E185 E193
4. T. Ikenoue, M. Akiyoshi, S. Fujitani, K. Okazaki, N. Kondo, and T. Maki Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-d-phenylalanine (A-4166) Br. J. Pharmacol. 120 1997 137 145
5. A. Okamura, A. Emoto, N. Koyabu, H. Ohtani, and Y. Sawada Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1 Br. J. Pharmacol. 137 2002 391 399
6. T. Terada, K. Sawada, H. Saito, Y. Hashimoto, and K. Inui Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2 Eur. J. Pharmacol. 392 2000 11 17
7. I.J. Hidalgo, T.J. Raub, and R.T. Borchardt Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability Gastroenterology 96 1989 736 749
8. K. Kuwayama, S. Miyauchi, R. Tateoka, H. Abe, and N. Kamo Fluorescein uptake by a monocarboxylic acid transporter in human intestinal Caco-2 cells Biochem. Pharmacol. 63 2002 81 88
9. S. Itagaki, M. Sugawara, M. Kobayashi, K. Miyazaki, and K. Iseki Mechanism of active secretion of phenolsulfonphthalein in the liver via MRP2 (abcc2), an organic anion transporter Drug Metab. Pharmacokinet. 18 2003 238 244
10. T. Itoh, S. Itagaki, Y. Sumi, T. Hirano, I. Takemoto, K. Iseki, Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2. Cancer Chemother. Pharmacol. in press
11. S. Itagaki, Y. Saito, S. Kubo, Y. Otsuka, Y. Yamamoto, M. Kobayashi, T. Hirano, and K. Iseki H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine J. Pharmacol. Exp. Ther. 312 2005 77 82
12. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol regent J. Biol. Chem. 193 1951 265 275
13. A.P. Halestrap, and N.T. Price The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation Biochem. J. 343 1999 281 299
14. B.E. Enerson, and L.R. Drewes Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery J. Pharm. Sci. 92 2003 1531 1544
15. N.T. Price, V.N. Jackson, and A.P. Halestrap Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past Biochem. J. 329 1998 321 328
16. G.F. Sud'ina, O.K. Mirzoeva, M.A. Pushkareva, G.A. Korshunova, N.V. Sumbatyan, and S.D. Varfolomeev Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties FEBS Lett. 329 1993 21 24
17. S. Singh, and B.B. Aggarwal Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) J. Biol. Chem. 270 1995 24995 25000
18. K. Yoshioka, T. Deng, M. Cavigelli, and M. Karin Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression Proc. Natl. Acad. Sci. U. S. A. 92 1995 4972 4976
19. K.A. Steinmetz, and J.D. Potter Vegetables, fruit, and cancer prevention J. Am. Diet. Assoc. 96 1996 1027 1039
20. M.H. Criqui, and B.L. Ringel Does diet or alcohol explain the French paradox? Lancet 344 1994 1719 1723
21. H. Adlercreutz, and W. Mazur Phyto-oestrogens and Western diseases Ann. Med. 29 1997 95 120
22. Y. Konishi, and S. Kobayashi Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal caco-2 cell monolayers J. Agric. Food Chem. 52 2004 2518 2526
23. Y. Konishi, S. Kobayashi, and M. Shimizu Tea polyphenols inhibit the transport of dietary phenolic acids mediated by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers J. Agric. Food Chem. 51 2003 7296 7302
24. Y. Konishi, K. Kubo, and M. Shimizu Structural effects of phenolic acids on the transepithelial transport of fluorescein in caco-2 cell monolayers Biosci. Biotechnol. Biochem. 67 2003 2014 2017
25. Y. Konishi, K. Hagiwara, and M. Shimizu Transepithelial transport of fluorescein in Caco-2 cell monolayers and use of such transport in in vitro evaluation of phenolic acid availability Biosci. Biotechnol. Biochem. 66 2002 2449 2457